PortfoliosLab logo

Amryt Pharma plc (AMYT)

Equity · Currency in USD · Last updated Aug 11, 2022

Company Info

ISINUS03217L1061
CUSIP03217L106
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$7.84
Year Range$6.30 - $12.24
EMA (50)$7.54
EMA (200)$8.80
Average Volume$74.42K
Market Capitalization$507.00M

AMYTShare Price Chart


Chart placeholderClick Calculate to get results

AMYTPerformance

The chart shows the growth of $10,000 invested in Amryt Pharma plc in Jul 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $6,969 for a total return of roughly -30.31%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%MarchAprilMayJuneJulyAugust
-19.17%
-4.71%
AMYT (Amryt Pharma plc)
Benchmark (^GSPC)

AMYTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M11.68%7.97%
6M-24.76%-6.88%
YTD-27.41%-11.66%
1Y-23.06%-5.01%
5Y-15.86%14.54%
10Y-15.86%14.54%

AMYTMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-6.39%-30.96%18.48%1.57%-4.76%-12.62%3.86%7.99%
2021-5.58%10.25%-5.50%-5.24%-10.98%3.23%-15.00%7.66%8.51%-12.00%-6.23%8.65%
2020-2.31%0.18%12.26%4.00%-2.76%13.28%

AMYTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Amryt Pharma plc Sharpe ratio is -0.55. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.55
-0.25
AMYT (Amryt Pharma plc)
Benchmark (^GSPC)

AMYTDividend History


Amryt Pharma plc doesn't pay dividends

AMYTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-46.85%
-12.22%
AMYT (Amryt Pharma plc)
Benchmark (^GSPC)

AMYTWorst Drawdowns

The table below shows the maximum drawdowns of the Amryt Pharma plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Amryt Pharma plc is 57.29%, recorded on Mar 7, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-57.29%Feb 17, 2021266Mar 7, 2022
-16.67%Sep 10, 202010Sep 23, 202031Nov 5, 202041
-9.82%Nov 16, 202011Dec 1, 20204Dec 7, 202015
-8.44%Jul 22, 20207Jul 30, 202028Sep 9, 202035
-6.07%Jan 4, 20215Jan 8, 202121Feb 9, 202126
-5.59%Dec 8, 202013Dec 24, 20204Dec 31, 202017
-4.35%Jul 17, 20201Jul 17, 20202Jul 21, 20203
-4.26%Jul 15, 20201Jul 15, 20201Jul 16, 20202
-3.58%Nov 6, 20201Nov 6, 20201Nov 9, 20202
-2.22%Jul 9, 20201Jul 9, 20202Jul 13, 20203

AMYTVolatility Chart

Current Amryt Pharma plc volatility is 34.15%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%MarchAprilMayJuneJulyAugust
34.15%
16.23%
AMYT (Amryt Pharma plc)
Benchmark (^GSPC)